+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


ChemoCentryx Inc (CCXI) - Financial and Strategic SWOT Analysis Review

  • ID: 4284652
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


ChemoCentryx Inc (ChemoCentryx) is a biopharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases, and inflammatory disorders. The company's pipeline products include C5aR programs, CCR2 program, CCR9 program, and CCR1 program. ChemoCentryx’s C5aR Program is for the treatment of anti-neutrophil cytoplasmic antibody associated renal vasculitis. The company’s CCR2 Program provides CCX140 for the treatment of diabetic nephropathy, a form of kidney disease and CCX872 for the treatment of pancreatic cancer. Its CCR9 Program is for the treatment of patients with Crohn's disease and CCX507 is for the treatment of inflammatory bowel disease. ChemoCentryx is headquartered in Mountain View, California, the US.

ChemoCentryx Inc Key Recent Developments

Jan 08, 2018: ChemoCentryx Strengthens Senior Executive Team with the Appointment of William Fairey as Executive Vice President and Chief Operating Officer
Nov 07, 2017: ChemoCentryx Reports Third Quarter 2017 Financial Results and Recent Highlights
Aug 08, 2017: ChemoCentryx Reports Second Quarter 2017 Financial Results and Recent Highlights
May 10, 2017: ChemoCentryx Reports First Quarter 2017 Financial Results
Mar 14, 2017: ChemoCentryx Reports Fourth Quarter and Full Year 2016 Financial Results

This comprehensive SWOT profile of ChemoCentryx Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ChemoCentryx Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • ChemoCentryx Inc - Key Information
  • ChemoCentryx Inc - Overview
  • ChemoCentryx Inc - Key Employees
  • ChemoCentryx Inc - Key Employee Biographies
  • ChemoCentryx Inc - Key Operational Heads
  • ChemoCentryx Inc - Major Products and Services
  • ChemoCentryx Inc - History
  • ChemoCentryx Inc - Company Statement
  • ChemoCentryx Inc - Locations And Subsidiaries
  • ChemoCentryx Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • ChemoCentryx Inc - Business Description
  • ChemoCentryx Inc - Corporate Strategy
  • ChemoCentryx Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • ChemoCentryx Inc - Strengths
  • ChemoCentryx Inc - Weaknesses
  • ChemoCentryx Inc - Opportunities
  • ChemoCentryx Inc - Threats
  • ChemoCentryx Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • ChemoCentryx Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • ChemoCentryx Inc, Key Information
  • ChemoCentryx Inc, Key Ratios
  • ChemoCentryx Inc, Share Data
  • ChemoCentryx Inc, Major Products and Services
  • ChemoCentryx Inc, History
  • ChemoCentryx Inc, Key Employees
  • ChemoCentryx Inc, Key Employee Biographies
  • ChemoCentryx Inc, Key Operational Heads
  • ChemoCentryx Inc, Other Locations
  • ChemoCentryx Inc, Subsidiaries
  • ChemoCentryx Inc, Key Manufacturing facilities
  • ChemoCentryx Inc, Key Competitors
  • ChemoCentryx Inc, SWOT Analysis
  • ChemoCentryx Inc, Ratios based on current share price
  • ChemoCentryx Inc, Annual Ratios
  • ChemoCentryx Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • ChemoCentryx Inc, Performance Chart
  • ChemoCentryx Inc, Ratio Charts
Note: Product cover images may vary from those shown